AU Patent

AU2009279944A1 — Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

Assigned to Medivation Technologies LLC · Expires 2010-02-11 · 16y expired

What this patent protects

Patent listed against Talzenna.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009279944A1
Jurisdiction
AU
Classification
—
Expires
2010-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Medivation Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.